SIC 2834 – Pharmaceutical Preparations
| Valuation | |
|---|---|
| Market Cap ($M) | 11.68 |
| Enterprise Value ($M) | -8.31 |
| Book Value ($M) | 20.01 |
| Book Value / Share | 5.33 |
| Price / Book | 0.58 |
| NCAV ($M) | 4.47 |
| NCAV / Share | 1.19 |
| Price / NCAV | 2.62 |
| Profitability (mra) | |
|---|---|
| Return on Invested Capital (ROIC) | -1.07 |
| Return on Assets (ROA) | -0.63 |
| Return on Equity (ROE) | -1.28 |
| Liquidity (mrq) | |
|---|---|
| Quick Ratio | 3.05 |
| Current Ratio | 3.46 |
| Balance Sheet (mrq) ($M) | |
|---|---|
| Current Assets | 28.22 |
| Assets | 43.77 |
| Liabilities | 23.75 |
| Debt | n/a |
| Equity | n/a |
| Income Statement (mra) ($M) | |
|---|---|
| Revenue | 0.00 |
| Operating Income | 0.00 |
| Net Income | 0.00 |
| Cash Flow Statement (mra) ($M) | |
|---|---|
| Cash From Operations | 0.00 |
| Cash from Investing | 0.00 |
| Cash from Financing | 0.00 |
(click for more detail) |
|
| File Date | Form | Activist 13D/G Investors | Ownership (%) |
Change (%) |
|---|---|---|---|---|
| 13D/A | Goodwood Inc. | 8.20 | 16.11 |
| Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
|---|---|---|---|---|
(click for more detail) |
||||
| Date | Insider Trades | Code | Shares | Value |
|---|---|---|---|---|
(click for more detail) |
||||
| Short Volume | |||
|---|---|---|---|
| Market Date | Short Volume | Total Volume | Short Volume Ratio |
| 17,813 | 56,818 | 31.35 | |
| 23,950 | 154,588 | 15.49 | |
| 2,580 | 3,431 | 75.20 | |
| 315 | 902 | 34.92 | |
| 3,435 | 11,795 | 29.12 | |
(click for more detail) |
|||
| Similar Companies | |
|---|---|
| CRIS – Curis, Inc. | CRVO – CervoMed Inc. |
| CSBR – Champions Oncology, Inc. | CTXR – Citius Pharmaceuticals, Inc. |
| CUE – Cue Biopharma, Inc. |
Financial data and stock pages provided by
Fintel.io